FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3165751676> ?p ?o ?g. }

• W3165751676 endingPage "e26190" @default.
• W3165751676 startingPage "e26190" @default.
• W3165751676 abstract "Adalimumab is used as a first-line biologic agent in the management of moderate-to-severe hidradenitis suppurativa (HS). The objective of the present study was to evaluate the efficacy and safety of adalimumab in patients with moderate-to-severe HS.We performed a systematic review and meta-analysis according to Preferred Reporting Items for Systematic reviews and Meta-Analysis guidelines. Pooled estimates, namely standardized mean difference (SMD) and relative risk (RR), were calculated using random-effect model with trial sequential analysis. Small study effects were examined using the Doi plot. Certainty of evidence (CoE) was assessed using The Grading of Recommendations Assessment, Development, and Evaluation approach, and number-needed-to-treat (NNT) was calculated.Five randomized controlled trials, involving 1014 patients, were included. We performed subgroup analysis of adalimumab administered subcutaneously both weekly and every other week. Adalimumab administered weekly was associated with better clinical response achievement (RR 1.76, 95% confidence interval [95% CI] 1.35-2.29; trial sequential analysis TSA-adjusted CI 1.01-3.08; CoE: low; NNT = 5) and a significant improvement in modified Sartorius score (SMD = -0.45, 95% CI = -0.76 to -0.13; CoE: very low; NNT = 10) and dermatology life quality index (DLQI) (SMD -0.47, 95% CI -0.61 to -0.32; CoE: low; NNT = 10). Nevertheless, adalimumab administered every other week showed an improvement only in modified Sartorius score. The pooled RRs of adverse events in both groups revealed no statistical significance when compared with the placebo.Adalimumab administered weekly resulted in not only better clinical responses than placebo but also significantly improved disease severity and quality of life of patients with moderate-to-severe HS. Our study provides supporting evidence to the current guidelines and aids decision-making in the application of adalimumab in HS management." @default.
• W3165751676 created "2021-06-07" @default.
• W3165751676 creator A5003044221 @default.
• W3165751676 creator A5030802828 @default.
• W3165751676 creator A5072402210 @default.
• W3165751676 date "2021-06-04" @default.
• W3165751676 modified "2023-10-14" @default.
• W3165751676 title "Efficacy and safety of adalimumab in hidradenitis suppurativa" @default.
• W3165751676 cites W1490634881 @default.
• W3165751676 cites W1581869568 @default.
• W3165751676 cites W1965385672 @default.
• W3165751676 cites W197423303 @default.
• W3165751676 cites W2009688763 @default.
• W3165751676 cites W2021081313 @default.
• W3165751676 cites W2024102731 @default.
• W3165751676 cites W204046373 @default.
• W3165751676 cites W2049852456 @default.
• W3165751676 cites W2057672284 @default.
• W3165751676 cites W2068176248 @default.
• W3165751676 cites W2094916253 @default.
• W3165751676 cites W2119605658 @default.
• W3165751676 cites W2123039495 @default.
• W3165751676 cites W2125435699 @default.
• W3165751676 cites W2131882149 @default.
• W3165751676 cites W2149371387 @default.
• W3165751676 cites W2156098321 @default.
• W3165751676 cites W2160965670 @default.
• W3165751676 cites W2167251944 @default.
• W3165751676 cites W2252504338 @default.
• W3165751676 cites W2287642010 @default.
• W3165751676 cites W2503109448 @default.
• W3165751676 cites W2588302396 @default.
• W3165751676 cites W2621228814 @default.
• W3165751676 cites W2767117873 @default.
• W3165751676 cites W2768740770 @default.
• W3165751676 cites W2785647181 @default.
• W3165751676 cites W2788093269 @default.
• W3165751676 cites W2799972028 @default.
• W3165751676 cites W2887140750 @default.
• W3165751676 cites W2890730116 @default.
• W3165751676 cites W2894720168 @default.
• W3165751676 cites W2923722987 @default.
• W3165751676 cites W2941504913 @default.
• W3165751676 cites W2944902556 @default.
• W3165751676 cites W2954832680 @default.
• W3165751676 cites W2966329906 @default.
• W3165751676 cites W2970684805 @default.
• W3165751676 cites W2972957964 @default.
• W3165751676 cites W2979544789 @default.
• W3165751676 cites W2991792334 @default.
• W3165751676 cites W3009296081 @default.
• W3165751676 cites W3016203880 @default.
• W3165751676 cites W3019350884 @default.
• W3165751676 cites W3043383702 @default.
• W3165751676 doi "https://doi.org/10.1097/md.0000000000026190" @default.
• W3165751676 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8183777" @default.
• W3165751676 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34087885" @default.
• W3165751676 hasPublicationYear "2021" @default.
• W3165751676 type Work @default.
• W3165751676 sameAs 3165751676 @default.
• W3165751676 citedByCount "5" @default.
• W3165751676 countsByYear W31657516762021 @default.
• W3165751676 countsByYear W31657516762022 @default.
• W3165751676 countsByYear W31657516762023 @default.
• W3165751676 crossrefType "journal-article" @default.
• W3165751676 hasAuthorship W3165751676A5003044221 @default.
• W3165751676 hasAuthorship W3165751676A5030802828 @default.
• W3165751676 hasAuthorship W3165751676A5072402210 @default.
• W3165751676 hasBestOaLocation W31657516761 @default.
• W3165751676 hasConcept C126322002 @default.
• W3165751676 hasConcept C141071460 @default.
• W3165751676 hasConcept C142724271 @default.
• W3165751676 hasConcept C168563851 @default.
• W3165751676 hasConcept C187960798 @default.
• W3165751676 hasConcept C197934379 @default.
• W3165751676 hasConcept C204787440 @default.
• W3165751676 hasConcept C27081682 @default.
• W3165751676 hasConcept C2776002364 @default.
• W3165751676 hasConcept C2779134260 @default.
• W3165751676 hasConcept C2780132546 @default.
• W3165751676 hasConcept C44249647 @default.
• W3165751676 hasConcept C67774102 @default.
• W3165751676 hasConcept C71924100 @default.
• W3165751676 hasConcept C82789193 @default.
• W3165751676 hasConcept C95190672 @default.
• W3165751676 hasConceptScore W3165751676C126322002 @default.
• W3165751676 hasConceptScore W3165751676C141071460 @default.
• W3165751676 hasConceptScore W3165751676C142724271 @default.
• W3165751676 hasConceptScore W3165751676C168563851 @default.
• W3165751676 hasConceptScore W3165751676C187960798 @default.
• W3165751676 hasConceptScore W3165751676C197934379 @default.
• W3165751676 hasConceptScore W3165751676C204787440 @default.
• W3165751676 hasConceptScore W3165751676C27081682 @default.
• W3165751676 hasConceptScore W3165751676C2776002364 @default.
• W3165751676 hasConceptScore W3165751676C2779134260 @default.
• W3165751676 hasConceptScore W3165751676C2780132546 @default.
• W3165751676 hasConceptScore W3165751676C44249647 @default.
• W3165751676 hasConceptScore W3165751676C67774102 @default.

• next